{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T05:24:40Z","timestamp":1790659480751,"version":"4.1.0"},"reference-count":43,"publisher":"Public Library of Science (PLoS)","issue":"7","license":[{"start":{"date-parts":[[2013,7,2]],"date-time":"2013-07-02T00:00:00Z","timestamp":1372723200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0067578","type":"journal-article","created":{"date-parts":[[2013,7,2]],"date-time":"2013-07-02T21:35:17Z","timestamp":1372800917000},"page":"e67578","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":16,"title":["Glucagon-Like Peptide-1 Secretory Function as an Independent Determinant of Blood Pressure: Analysis in the Tanno-Sobetsu Study"],"prefix":"10.1371","volume":"8","author":[{"given":"Mayumi","family":"Yoshihara","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Akasaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hirofumi","family":"Ohnishi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takayuki","family":"Miki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tetsuaki","family":"Furukawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoshi","family":"Yuda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shigeyuki","family":"Saitoh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tetsuji","family":"Miura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2013,7,2]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.1053\/j.gastro.2007.03.054","article-title":"Biology of incretins: GLP-1 and GIP","volume":"132","author":"LL Baggio","year":"2007","journal-title":"Gastroenterology"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1093\/cvr\/cvs123","article-title":"GLP-1 and cardioprotection: from bench to bedside","volume":"94","author":"S Ravassa","year":"2012","journal-title":"Cardiovasc Res"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"3717","DOI":"10.1210\/jcem.86.8.7750","article-title":"Determinants of the impaired secretion of glucagon-like peptide-1 in type 2 diabetic patients","volume":"86","author":"MB Toft-Nielsen","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"609","DOI":"10.2337\/diabetes.50.3.609","article-title":"Vilsboll T, Krarup T, Deacon CF, Madsbad S, Holst JJ 2001) Reduced postprandial concentrations of intact biologically active glucagon-like peptide 1 in type 2 diabetic patients","volume":"50","journal-title":"Diabetes"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"3055","DOI":"10.1210\/jc.2003-031403","article-title":"Glucagon-like peptide 1 induces natriuresis in healthy subjects and in insulin-resistant obese men","volume":"89","author":"JP Gutzwiller","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1159\/000094334","article-title":"Glucagon-like peptide 1 is involved in sodium and water homeostasis in humans","volume":"73","author":"JP Gutzwiller","year":"2006","journal-title":"Digestion"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1097\/00004872-200306000-00012","article-title":"Antihypertensive effect of glucagon-like peptide 1 in Dahl salt-sensitive rats","volume":"21","author":"M Yu","year":"2003","journal-title":"J Hypertens"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/S0140-6736(08)61246-5","article-title":"Liraglutide versus glimepiride monotherapy for type 2 diabetes (LEAD-3 Mono): a randomised, 52-week, phase III, double-blind, parallel-treatment trial","volume":"373","author":"A Garber","year":"2009","journal-title":"Lancet"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.2337\/dc08-2124","article-title":"Efficacy and safety of the human glucagon-like peptide-1 analog liraglutide in combination with metformin and thiazolidinedione in patients with type 2 diabetes (LEAD-4 Met+TZD)","volume":"32","author":"B Zinman","year":"2009","journal-title":"Diabetes Care"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1111\/j.1463-1326.2009.01075.x","article-title":"The safety and efficacy of liraglutide with or without oral antidiabetic drug therapy in type 2 diabetes: an overview of the LEAD 1\u20135 studies","volume":"11","author":"L Blonde","year":"2009","journal-title":"Diabetes, Obesity and Metabolism"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1038\/ajh.2009.245","article-title":"Effects of exenatide on systolic blood pressure in subjects with type 2 diabetes","volume":"23","author":"T Okerson","year":"2010","journal-title":"Am J Hypertens"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.2337\/dc06-0222","article-title":"Incidence of type 2 diabetes in individuals with central obesity in a rural Japanese population: the Tanno and Sobetsu Study","volume":"29","author":"H Ohnishi","year":"2006","journal-title":"Diabetic Care"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1161\/HYPERTENSIONAHA.112.201129","article-title":"Effects of parental hypertension on longitudinal trends in blood pressure and plasma metabolic profile: mixed-effects model analysis","volume":"60","author":"K Mitsumata","year":"2012","journal-title":"Hypertension"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1053\/j.ajkd.2008.12.034","article-title":"Revised equations for estimated GFR from serum creatinine in Japan","volume":"53","author":"S Matsuo","year":"2009","journal-title":"Am J Kidney Dis"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1007\/BF00280883","article-title":"Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man","volume":"28","author":"DR Matthews","year":"1985","journal-title":"Diabetologia"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.2337\/diacare.22.9.1462","article-title":"Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp","volume":"22","author":"M Matsuda","year":"1999","journal-title":"Diabetes Care"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1530\/eje.0.1430593","article-title":"Circulating levels of incretin hormones and amylin in the fasting state and after oral glucose in GH-deficient patients before and after GH replacement: a placebo-controlled study","volume":"143","author":"JO J\u00f8rgensen","year":"2000","journal-title":"Eur J Endocrinol"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1093\/ajcn\/84.3.556","article-title":"High fasting plasma concentrations of glucagon-like peptide 1 are associated with higher resting energy expenditure and fat oxidation rates in humans","volume":"84","author":"N Pannacciulli","year":"2006","journal-title":"Am J Clin Nutri"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1038\/oby.2005.80","article-title":"Decreased glucagon like peptide 1 release after weight loss in overweight\/obese subjects","volume":"13","author":"TC Adam","year":"2005","journal-title":"Obes Res"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1159\/000339378","article-title":"Basal GLP-1 levels in morbidity obese patients following biliopancreatic diversion surgery","volume":"61","author":"D De Luis","year":"2012","journal-title":"Ann Nutr Metab"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"2974","DOI":"10.1038\/oby.2007.355","article-title":"Influence of BMI and gender on postprandial hormone responses","volume":"15","author":"JF Carroll","year":"2007","journal-title":"Obesity"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"M575","DOI":"10.1093\/gerona\/56.9.M575","article-title":"Effect of aging and diabetes on the enteroinsular axis","volume":"56","author":"J Korosi","year":"2001","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.clinbiochem.2012.11.023","article-title":"Serum levels of advanced glycation end products (AGEs) are independently correlated with circulating levels of dipeptidyl peptidase-4 (DPP-4) in humans","volume":"46","author":"N Tahara","year":"2013","journal-title":"Clin Biochem"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1177\/0091270006288215","article-title":"An open-label, parallel group study investigating the effects of age and gender on the pharmacokinetics of the once-daily glucagon-like peptide-1 analogue liraglutide","volume":"46","author":"B Damholt","year":"2006","journal-title":"J Clin Pharmacol"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1159\/000180972","article-title":"Physiological significance of gastrointestinal somatostatin","volume":"29","author":"V Schusdziarra","year":"1988","journal-title":"Horm Res"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/j.peptides.2009.11.008","article-title":"Effect of somatostatin analog on high-fat diet-induced metabolic syndrome: involvement of reactive oxygen species","volume":"31","author":"W Li","year":"2010","journal-title":"Peptides"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1210\/en.2008-0726","article-title":"Insulin regulates glucagon-like peptide-1 secretion from the enteroendocrine L cell","volume":"150","author":"GE Lim","year":"2009","journal-title":"Endocrinology"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.bbrc.2010.12.131","article-title":"Extendin-4, a glucagon-like peptide-1 receptor agonist, reduces intimal thickening after vascular injury","volume":"405","author":"H Goto","year":"2011","journal-title":"Biochem Biophys Res Commun"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.ejphar.2012.11.057","article-title":"Extendin-4, a glucagon-like peptide-1 receptor agonist, attenuates neointimal hyperplasia after vascular injury","volume":"699","author":"Y Hirata","year":"2013","journal-title":"Eur J Pharmacol"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"E222","DOI":"10.1152\/ajpendo.00473.2012","article-title":"Protein kinase A mediates glucagon-like peptide 1-induced nitric oxide production and muscle microvascular recruitment","volume":"304","author":"Z Dong","year":"2013","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"F963","DOI":"10.1152\/ajprenal.00259.2012","article-title":"Natriuretic effect by exendin-4, but not the DPP-4 inhibitor alogliptin, is mediated via the GLP-1 receptor and preserved in obese type 2 diabetic mice","volume":"303","author":"T Rieg","year":"2012","journal-title":"Am J Physiol Renal Physiol"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1038\/nm.3128","article-title":"GLP-1 receptor activation and Epac2 link atrial natriuretic peptide secretion to control of blood pressure","volume":"19","author":"M Kim","year":"2013","journal-title":"Nat Med"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"E1209","DOI":"10.1152\/ajpendo.00237.2004","article-title":"Effects of glucagon-like peptide-1 on endothelial function in type 2 diabetes patients with stable coronary artery disease","volume":"287","author":"T Nystr\u00f6m","year":"2004","journal-title":"Am J Physiol Endocrionol Metab"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"683","DOI":"10.2337\/dc12-0763","article-title":"Effects of GLP-1 on forearm vasodilator function and glucose disposal during hyperinsulinemia in the metabolic syndrome","volume":"36","author":"M Tesauro","year":"2013","journal-title":"Diabetes Care"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1097\/MNH.0b013e328356bccd","article-title":"Novel role for the incretins in blood pressure regulation","volume":"21","author":"P Yerram","year":"2012","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"R874","DOI":"10.1152\/ajpregu.00153.2008","article-title":"Effects of glucagon-like peptide-1, yohimbine and nitrergic modulation on sympathetic and parasympathetic activity in humans","volume":"295","author":"AE Bharucha","year":"2008","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1042\/cs0950719","article-title":"Subcutaneous glucagon-like peptide-1 (7\u201336) amide is insulinotropic and can cause hypoglycemia in fasted healthy subjects","volume":"95","author":"CM Edwards","year":"1998","journal-title":"Clin Sci"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1111\/j.1365-2125.2012.04214.x","article-title":"Investigation of the haemodynamic effects of exenatide in healthy male subjects","volume":"74","author":"B Mendis","year":"2012","journal-title":"Br J Clin Pharmacol"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"2256","DOI":"10.1007\/s00125-010-1831-8","article-title":"A glucagon-like peptide-1 (GLP-1) analogue, liraglutide, upregulates nitric oxide production and exerts anti-inflammatory actions in endothelial cells","volume":"53","author":"Y Hattori","year":"2010","journal-title":"Diabetologia"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.mce.2010.04.022","article-title":"Exendin-4 stimulates proliferation of human coronary artery endothelial cells through eNOS-, PKA-, and PI3K\/Akt-dependent pathways and requires GLP-1 receptor","volume":"325","author":"O Erdogdu","year":"2010","journal-title":"Mol Cell Endocrinol"},{"key":"ref41","first-page":"1407","article-title":"Glucagon-like peptide 1 prevents reactive oxygen species-induced endothelial cell senescence through the activation of the activation of protein kinase A. Arterioscler Thromb Vasc Biol","volume":"30","author":"H Oesburg","year":"2010"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"e303","DOI":"10.1097\/01.hjh.0000420501.61574.ea","article-title":"Relationship between blood pressure and oxidative stress via sodium intake: the Tanno and Sobetsu Study","volume":"30","author":"H Akasaka","year":"2012","journal-title":"[Abstract] J Hypertens"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1291\/hypres.30.887","article-title":"Report of the Working Group for Dietary Salt Reduction of the Japanese Society of Hypertension: (2) Assessment of salt intake in the management of hypertension","volume":"30","author":"Y Kawano","year":"2007","journal-title":"Hypertens Res"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0067578","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,9]],"date-time":"2020-05-09T07:17:22Z","timestamp":1589008642000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0067578"}},"subtitle":[],"editor":[{"given":"Angelo","family":"Scuteri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2013,7,2]]},"references-count":43,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2013,7,2]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0067578","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,7,2]]}}}